Biomarkers in systemic lupus erythematosus: II. Markers of disease activity
β Scribed by Gabor G. Illei; Edward Tackey; Larissa Lapteva; Peter E. Lipsky
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 212 KB
- Volume
- 50
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Objective To evaluate serum free light chains (FLC) as a putative biomarker of systemic lupus erythematosus (SLE) activity. ## Methods Seventyβfive SLE patients and 41 ageβ and sexβmatched rheumatoid arthritis (RA) controls were enrolled. Disease activity was assessed using the Sa
Forty-three patients taking chloroquine for systemic lupus erythematosus were followed by one ophthalmologist over a 5-year period. Visual field testing, color vision testing, and fluorescein angiography were performed. Retinopathy was detected in 7 patients (16%1, none of whom had hypertension or d